# Correlation Between Hepatic Fibrosis and Cardiovascular Risk Evaluated by Non-invasive Tests in Patients With NAFLD

> **NCT04774302** · — · COMPLETED · sponsor: **Clinique Pasteur** · enrollment: 292 (actual)

## Conditions studied

- NAFLD

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04774302
- **Lead sponsor:** Clinique Pasteur
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-18
- **Primary completion:** 2025-04-30
- **Final completion:** 2025-04-30
- **Target enrollment:** 292 (ACTUAL)
- **Last updated:** 2026-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04774302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04774302, "Correlation Between Hepatic Fibrosis and Cardiovascular Risk Evaluated by Non-invasive Tests in Patients With NAFLD". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04774302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*